Table 4.
Selected studies investigating autism spectrum disorder using iPSCs from patients.
iPSC Model (s) | Observation (s) | Implication (s) | References |
---|---|---|---|
The iPSCs differentiated to NPCs and neurons from ASD individuals with early brain overgrowth and non-ASD controls with normal brain size | The ASD-derived NPCs display faster proliferation than control-derived NPCs due to dysregulation of a β-catenin/BRN2 transcriptional cascade | Abnormal neurogenesis and synaptogenesis leading to functional defects in neuronal networks that could be rescued by the neurotrophic factor IGF-1 | Marchetto et al. [76] |
The iPSCs from ASD with macrocephaly differentiated to NSCs; iPSCs directly converted into iNs; generation of cerebral organoids | Dysregulation of specific transcriptional networks that caused aberrant neuronal maturation of ASD cortical neurons | The ASD-associated neurodevelopmental aberrations are triggered by a pathological priming of gene regulatory networks during early neural development | Shafer et al., 2019 [77] |
Organoids derived from ASD-iPSCs | The ASD-derived organoids exhibit an overproduction of GABAergic inhibitory neurons, due to the overexpression of the transcription factor FOXG1 | Cortical organoids of ASD patients show exuberant GABAergic differentiation and no change in glutamate neuron types, which together cause an imbalance in glutamate/GABA neuron ratio | Mariani et al., 2016 [78] |
The iPSCs from ASD without macrocephaly differentiated to cortical and midbrain neurons | The ASD-iPSCs differentiated to cortical neurons displayed impaired neural differentiation. These cellular phenotypes occurred in the absence of alterations in cell proliferation during cortical differentiation, in contrast to previous studies | Patients with ASD but without macrocephaly exhibited impairments in neurogenesis compared with those from neurotypical individuals | Adhya et al., 2021 [79] |
The NPCs derived from FMR1-knockout iPSCs as a model for studying FMRP functions and FXS pathology |
Altered expression of neural differentiation markers, MRP-deficient neurons showed less spontaneous calcium bursts, corrected by the protein kinase inhibitor LX7101 | Loss of FMRP resulted in abnormal differentiation accompanied by impaired neuronal activity | Sunamura et al. [80] |
Both 2D and 3D FXS models based on isogenic FMR1 knock-out mutant and wild-type human iPSC lines | Cortical neurons derived from FMRP-deficient iPSCs exhibit altered gene expression and impaired differentiation when compared with the healthy counterpart | The FMRP is required to correctly support neuronal and glial cell proliferation, and to set the correct excitation/inhibition ratio in the developing brain | Brighi et al. [81] |
Human SH-SY5Y neuroblastoma cells and FXS fibroblast-derived iPSCs | The FMRP deficiency results in hyperactivated nonsense-mediated mRNA decay (NMD). The key NMD factor UPF1 binds directly to FMRP, promoting FMRP binding to NMD targets | The FMRP acts as an NMD repressor. In the absence of FMRP, NMD targets are relieved from FMRP-mediated repression. Many abnormalities in FMRP-deficient cells are attributable, either directly or indirectly, to misregulated NMD | Kurosaky et al. [82] |
ASD: Autism Spectrum Disorder; FXS: Fragile X syndrome; NSCs: neural stem cells; iNs: induced neurons; IGF-1: insulin-like growth factor 1; FMRP: fragile X mental retardation protein.